Latest News & Features
Europe
The drugmaker’s attempt to extend protection for a fast-growing oestrogen-free contraceptive ran into a landmark EU ruling, with the court not persuaded to read it narrowly. 24 March 2026
Europe
The European Patent Office’s Technology Dashboard reveals only a slight increase in medtech filings, and drops in biotech and pharma, against an overall healthy backdrop. 24 March 2026
Big Pharma
With Novo Nordisk's core semaglutide patent expired in India last week, the company that built one of the most successful drugs in pharmaceutical history is already fighting on a new front. So what comes next? 23 March 2026
Asia
As the patent protecting semaglutide—the drug that made Novo Nordisk one of Europe's most valuable companies—expires in ten countries, the pressure mounts for prices and market leaders alike. 20 March 2026
Americas
Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry technology, Apple is not barred from using it, says a California judge. 19 March 2026
Big Pharma
The Swiss generics giant secures global commercialisation rights as partnership targets multi-billion-dollar loss-of-exclusivity opportunity. 19 March 2026
Careers
A new partner hire at the firm brings rare depth across both the ITC and district courts in technology and life sciences. 18 March 2026
Americas
Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios. 17 March 2026
Careers
New recruit, who has worked on more than 150 infringement cases, will join the firm’s disputes practice in Düsseldorf and strengthen its UPC offering. 17 March 2026
Big Pharma
Research from the International Trademark Association finds in-house counsel taking on more strategic work while facing shrinking budgets, prompting a shift towards alternative billing and greater use of AI. 16 March 2026